April 04,2007
Grassley Seeks Marketing and Safety Documents from Major Drug Maker
WASHINGTON — Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa. Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health.
The text of Grassley’s letter can be found in the printer-friendly version of this news release.
###
Next Article Previous Article
Recent News
- Wyden, Sanders Demand Answers from Trump Administration Over Mass Layoffs that Threaten the Wellbeing of Children and Families
- Wyden, Sanders Demand Answers from Trump Administration Over Mass Layoffs that Threaten the Wellbeing of Children and Families
- Wyden, Cortez Masto Call for Criminal Investigation into Evidence of Fraud by Promoters Affiliated with IRS Nominee Billy Long
- Wyden Statement on Social Security Using Death Master List to Revoke Social Security Numbers
- Wyden, Whitehouse Lead Colleagues in Demanding Answers on DOGE’s Access to the Sensitive National Child Support Database